In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Clinical Trials - Diseases by specialty group
Leukemia 4
-
Protocol ID
- Associated disease
- Title
-
IIT-HOAG-PAVIR
- Myeloma/Myelodysplastic Syndrome (MDS)
- PAViR: Using Virtual Reality to Increase Physical Activity in Youths with Cancer
-
IIT-MOSKOP-MABD
- Myeloma/Myelodysplastic Syndrome (MDS)
- Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation with Alpha/Beta T-Cell and B-Cell Depletion for Patients with Hematologic Malignancies with Targeted ATG Dosing Pilot Study, IDE 13641
-
NMDP-UMCC2018-081
- Myeloma/Myelodysplastic Syndrome (MDS)
- A Phase 1/2 Multi-Center Trial of Vorinistat for Graft vs Host Disease Prevention in Children, Adolescents, and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
-
PBMTC-ONC1401
- Myeloma/Myelodysplastic Syndrome (MDS)
- The Role of KIR-Favorably Mismatched Haploidentical Transplantation and KIR-Polymorphisms in Determining Outcomes of Children with ALL/AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
